Previous studies have demonstrated that Sphk1 expression levels are increased in the colons of patients with ulcerative colitis (UC) or colorectal cancers [22,40], and the increased expression of Sphk1 and S1P is associated with poor outcomes. Here, MBTPS1 is linked to colorectal cancer.